Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 353.60
Bid: 354.80
Ask: 355.40
Change: 5.60 (1.61%)
Spread: 0.60 (0.169%)
Open: 350.20
High: 356.60
Low: 348.80
Prev. Close: 348.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QinetiQ enters next phase of growth in the US

13 Jul 2020 15:51

RNS Number : 8624S
QinetiQ Group plc
13 July 2020
 

News Release

 

QinetiQ Group plc

QinetiQ enters next phase of growth in the US

13 July 2020. QinetiQ announces that it has signed an agreement with the US Defense Counterintelligence & Security Agency (DCSA) to operate all of its US defence and security operations under a new Special Security Agreement (SSA). This agreement replaces the prior Proxy Agreement for the QinetiQ North America business and also covers all operations undertaken through the recent MTEQ acquisition (completed in December 2019).

 

The SSA enables the bringing together of all of QinetiQ's US defence and security operations under a single entity, QinetiQ Inc, and as a single QinetiQ brand. This agreement fundamentally changes and improves how QinetiQ approaches the largest defence market in the world and is a major milestone in the growth strategy for QinetiQ.

 

The US business is led by Mary Williams, former MTEQ President and CEO. The Board is set in accordance with DCSA standards and comprises The Honorable John Hillen (QinetiQ Inc Chair), Steve Wadey (QinetiQ CEO), David Smith (QinetiQ CFO), Directors Dr Pamela Drew and Tom Mills, with Mary Williams.

 

The unified US business employs 700 people across our main sites in Virginia, Massachusetts and Pennsylvania and combines world leading expertise in robotics and autonomy with our sensors and integration capability. These aligned capabilities and support from the wider Group are key to QinetiQ's US growth strategy, enabling QinetiQ to create a business focused on 'mission-led innovation'; a strategy that will deliver solutions critical to next generation warfighting capability for the US.

 

QinetiQ's recent win of the Robotic Combat Vehicle Light (RCV-L) programme is a great example of the strength of the combined capabilities of the new QinetiQ US business, leveraging the combination of expertise in advanced sensors, robotics and autonomy.

 

Steve Wadey, QinetiQ Group Plc CEO, said:

 

"Building on the acquisition of MTEQ, this new Special Security Agreement enables us to fundamentally reset the way we go to market as an integrated global defence and security company. The way we have come together as a new team, and worked with the DCSA, to achieve the signing of this vital change at pace is notable. The SSA will enable much greater levels of collaboration, making it easier to build integrated business capture teams and to leverage investment across the Group. It will have a profound and positive impact on the way we work, building bigger propositions that add value to the US warfighter."

 

Mary Williams, QinetiQ Inc President and CEO, said:

 

"We are now able to move to our next phase of integration for our US business, seeking to fully leverage the range of talent within our US business, and tapping into the capabilities and investments of QinetiQ. This is an exciting time as we develop and execute our mission-led innovation strategy to deliver the adaptable products and services that our armed forces need, and at a pace that exceeds their expectations."

 

About QinetiQ:

 

QinetiQ is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

 

 

For further information please contact:

 

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries)

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKNBQQBKDFOD
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:01 amRNSDirectorate Change, Leadership Team appointments
16th Apr 20247:00 amRNSQinetiQ Group plc Fourth Quarter Trading Update
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20244:35 pmRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSDirectorate Change
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20245:24 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20244:05 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20245:21 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20241:54 pmRNSDirector Declaration
5th Mar 202412:08 pmRNSDirector Declaration
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20244:00 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.